Back to news

Organigram to Acquire Aurora and Establish a Global Cannabis Leader

Business Wire•03/11/2026•09:16 ET
0

Key Highlights

  • ➤Organigram to acquire Aurora for C$7.80 per share, valuing Aurora at approximately C$561 million
  • ➤Offer represents 93% premium to Aurora’s August 10, 2026 unaffected share price
  • ➤Transaction offers Aurora shareholders cash, Organigram shares, or combined consideration, subject to proration
  • ➤Combined company expects more than C$50 million in identified synergies
  • ➤BAT to invest C$187.5 million in Organigram through a concurrent private placement
  • ➤Transaction expected to close in January 2027, pending shareholder and regulatory approvals

Expert Statements

James Yamanaka, CEO of Organigram

“This Transaction is a defining step in Organigram’s strategy to build a disciplined, global cannabis leader. By bringing together Aurora’s established global medical cannabis platform with our Canadian operations and growing international footprint, we are creating a larger, stronger, and more diversified company. We are excited to build on our complementary operations, expertise, capital resources, and cultures to accelerate growth, meet the growing global demand, and drive long-term profitable growth.”

Miguel Martin, Executive Chairman and CEO of Aurora

“Combining with Organigram will accelerate Aurora’s international growth strategy by strengthening commercial execution, expanding our product and R&D capabilities, and extending our global operating network. For Aurora’s shareholders, the Transaction is the result of a robust strategic review process and delivers compelling value today, meaningful choice in how they receive it and the opportunity to participate in the future of a leading cannabis company.”

Organigram to Acquire Aurora and Establish a Global Cannabis Leader

* Organigram to acquire Aurora for C$7.80 per Aurora Common Share; Aurora shareholders will have the option to receive such Consideration in cash, Organigram shares or a combination of both, subject to proration. Transaction provides Aurora shareholders with certainty of value, meaningful immediate liquidity and participation in the combined entity

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in